[ORGANIZATION]
Ocrevus
Featured in 4 tracked stories · first seen
Situations
EMA CHMP and EU Commission medicinal product approvals
3 clusters · 24 sources · last updated
Latest: European Commission approves Ocrevus for pediatric multiple sclerosis
In September 2026, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended the approval of 12 new medicines and therapeutic extensions for 11 existing ones. Among the
Anvisa seizure of irregular Ocrevus batches in Brazil
2 clusters · 11 sources · last updated
Latest: Anvisa orders seizure of irregular Ocrevus lots in Brazil
Brazil’s National Health Surveillance Agency (Anvisa) ordered the seizure of two irregular batches of the multiple sclerosis medication Ocrevus (ocrelizumab) 300 mg/10 ml, identified as H7953B14 and H7953B06. Although t